[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Phenox GmbH\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":88},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,47],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":22,"studyType":23,"phases":4,"briefSummary":24,"conditions":25,"keywords":27,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":39,"completionDateStruct":41,"leadSponsor":43,"locationsCount":46},"100650379","pmcf-registry-to-describe-the-safety-and-performance-of-p64-p48-mw-and-p64-mw-in-france-100650379",false,"NCT07748572","PMCF Registry to Describe the Safety and Performance of p64, p48 MW and p64 MW in France","CEFloW (Clinical Experience With Flow Diverter With and Without Movable Wire)","CEFloW","Inclusion Criteria:\n\n* 1\\. Age ≥ 18 years and legally of age.\n* 2\\. The patient has intracranial aneurysm(s) \\* and is treated or planned to be treated with p64, p48 MW or p64 MW Devices. (\\*cases of ruptured aneurysms in the context of a staged procedure or not treatable by another technique, and cases of multiple aneurysms are eligible)\n* 3\\. The patient or his\u002Fher legal representative (in case the patient does not have the capacity due to his\u002Fher clinical condition), does not object to the collection and processing of the data specified in the protocol.\n\nExclusion Criteria:\n\n* 1\\. Participation in an interventional study modifying standard patient care management (e.g. COATING study)\n* 2\\. State or circumstance that does not allow the patient to undergo the standard site's follow-up for aneurysm treatment","ALL","18 Years",{"count":20,"type":21},200,"ESTIMATED","12 Months","OBSERVATIONAL","To evaluate safety and performance of the phenox GmbH Flow Diverter p64, p64 MW, and p48MW in France, this registry will include subjects with intracranial aneurysms (anterior and posterior) who are treated with a phenox GmbH Flow Diverter. The subjects will be treated according to the standard of care in the participating sites.",[26],"Intracranial Aneurysms",[28,29,30,31,32,33],"Vascular Diseases","Intracranial Arterial Diseases","Cerebrovascular Disorders","Brain Diseases","Intracranial Aneurysm","Aneurysm","RECRUITING","2026-08-04",{"date":37,"type":38},"2026-08-05","ACTUAL",{"date":40,"type":38},"2025-03-07",{"date":42,"type":21},"2028-12",{"name":44,"class":45},"Phenox GmbH","INDUSTRY",11,{"id":48,"slug":49,"hasResults":11,"nctId":50,"briefTitle":51,"officialTitle":52,"acronym":53,"eligibilityCriteria":54,"healthyVolunteers":11,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":55,"targetDuration":57,"studyType":23,"phases":4,"briefSummary":58,"conditions":59,"keywords":68,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":79,"lastUpdatePostDateStruct":80,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":87},"100629458","targeting-real-world-usage-in-stroke-treatment-100629458","NCT07474935","Targeting Real World Usage In Stroke Treatment","TRUST Registry - Targeting Real World Usage In Stroke Treatment A WallabyPhenox Hemorrhagic Stroke Registry","TRUST","Inclusion Criteria:\n\n* Subject treated or intended to be treated with at least one target registry device during the procedure (i.e., at least one attempt of introduction into the vasculature of the subject),\n* Non-opposition to data collection or informed consent provided by the subject or legal representative as per country-specific legislation.\n\nExclusion Criteria:\n\n* Participation in an interventional study modifying standard care management for all relevant indications,",{"count":56,"type":21},5000,"5 Years","TRUST Registry is an observational, prospective, long-term, post-market surveillance registry of subjects treated with WallabyPhenox flow modulation devices, stent systems, bifurcation aneurysm implants including their HPC variants (Hydrophilic Polymer Coating) where applicable as well as coil systems, and other adjunctive medical devices.\n\nThe overarching purpose of this registry is to carry out a proactive gathering, recording, and analysis of data on the safety, performance and usability of the devices as applied within the routine practice of the participating registry sites.",[60,61,62,63,64,65,66,67,26],"Saccular and Fusiform Aneurysms","Pseudoaneurysm","Vascular Dissection","Perforation","Bifurcation Aneurysms","Stenosis","Neurovascular Abnormalties","Wide-neck Aneurysm",[69,70,71,72,73,74,75,76,77,78],"TRUST Registry","Registry study","Flow Diverter","WallabyPhenox","p48 MW (HPC)","p64","Avenir Coil","p64 MW (HPC)","pEGASUS HPC","pCONUS 2 (HPC)","2026-03-11",{"date":81,"type":38},"2026-03-16",{"date":83,"type":38},"2026-01-29",{"date":85,"type":21},"2041-01",{"name":44,"class":45},13,""]